Compare Danaher Corporation (DHR) vs YieldMax Universe Fund of Option Income ETFs (YMAX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Danaher Corporation vs YieldMax Universe Fund of Option Income ETFs — how do they compare? Danaher Corporation trades at $201.32 (market cap $140.88B), while YieldMax Universe Fund of Option Income ETFs trades at $7.79. The key difference: Danaher Corporation pays a 0.8% dividend while YieldMax Universe Fund of Option Income ETFs pays none, and Danaher Corporation is trading nearer its 52-week high, YieldMax Universe Fund of Option Income ETFs nearer its low. Which is the better fit depends on your goals.
| DHR | YMAX | |
|---|---|---|
Market Cap | $140.88B | — |
Sector | Health | Income / Options Overlay |
52-Week High | $242.05 | $14.00 |
52-Week Low | $161.91 | $7.51 |
Enterprise Value | $153.66B | — |
Dividend Yield | 0.8% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Danaher (DHR) trades at $200.16, up 0.56% today, with a bullish technical signal from moving averages and strong analyst support. The company reported Q1 2026 EPS of $2.06, beating estimates of $1.94, marking the third consecutive quarterly beat. Revenue for 2025 was $24.57 billion with a net income margin of 14.89%, though margins have compressed from prior years. Recent news includes the acquisition of Masimo and a $172.5 million legal settlement finalized in April 2026.
The outlook remains positive with a consensus price target of $211.33, implying ~5.6% upside, supported by 69% buy ratings. Key risks include margin pressure, integration challenges from acquisitions, and macroeconomic sensitivity. The stock offers a dividend yield from its $0.40 quarterly payout, with solid cash flow generation offsetting debt levels.
YMAX trades at $7.82, down 1.26% today amid bearish technical signals with 16 sell indicators versus 1 buy. The ETF maintains weekly dividend distributions but faces scrutiny over its fund-of-funds structure and 1.33% fee. Recent articles highlight shrinking payouts and cost concerns, while technical analysis shows all moving averages signaling bearish momentum with neutral oscillators.
The outlook remains cautious as high fees and declining distributions pressure investor returns. Key risks include structural costs eroding yields and bearish technical momentum. Investment opportunity hinges on volatility-driven income generation, but current sentiment suggests limited upside without improved cost efficiency or market conditions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Danaher Corporation
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
Read more on DHR →About YieldMax Universe Fund of Option Income ETFs
YMAX is an actively managed 'fund of funds' that provides equal-weighted exposure to the full suite of YieldMax option income ETFs. It is designed to generate high current income by aggregating the premiums from various single-stock and thematic covered call strategies, offering a diversified approach to high-yield option investing.
Read more on YMAX →
